Brain Stimulation for Dyslexia
Trial Summary
The trial excludes individuals taking certain medications that lower the seizure threshold, so you may need to stop taking those specific medications. The protocol does not specify other medication restrictions.
Research shows that high frequency repetitive transcranial magnetic stimulation (hf-rTMS) can improve reading skills in adults with dyslexia by enhancing reading speed and accuracy. This treatment targets specific brain areas that are underactive in dyslexics, leading to better reading performance.
12345Repetitive transcranial magnetic stimulation (rTMS) has been studied for safety, and while it is generally considered safe, it has been associated with some risks, such as seizures. Guidelines have been developed to ensure its safe use, and it is important to follow recommended limits and monitoring procedures during treatment.
16789Transcranial Magnetic Stimulation (rTMS) is unique because it uses magnetic fields to stimulate specific brain areas that are underactive in people with dyslexia, potentially improving reading skills by enhancing neural pathways. Unlike traditional methods, it directly targets brain function rather than focusing solely on behavioral interventions.
12101112Eligibility Criteria
This trial is for older youth with dyslexia. Participants should be able to undergo brain stimulation and are interested in how it might affect learning new spoken words. Specific eligibility details aren't provided, so generally healthy individuals who meet the age requirement for 'older youth' may apply.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline MRI
Participants complete a baseline MRI session to assess the reading and language network
Treatment
Participants receive cTBS or sham stimulation followed by pseudoword discrimination and word learning tasks
Follow-up
Participants are monitored for retention of learned items 24 hours after each treatment session
Participant Groups
Transcranial Magnetic Stimulation is already approved in United States, Canada, European Union for the following indications:
- Major Depressive Disorder
- Obsessive Compulsive Disorder
- Major Depressive Disorder
- Major Depressive Disorder